Correlation Between AngioSoma and Protagenic Therapeutics

Can any of the company-specific risk be diversified away by investing in both AngioSoma and Protagenic Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AngioSoma and Protagenic Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between AngioSoma and Protagenic Therapeutics, you can compare the effects of market volatilities on AngioSoma and Protagenic Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AngioSoma with a short position of Protagenic Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of AngioSoma and Protagenic Therapeutics.

Diversification Opportunities for AngioSoma and Protagenic Therapeutics

-0.18

Correlation Coefficient

AngioSoma  Protagenic Therapeutics

Good diversification

The 3 months correlation between AngioSoma and Protagenic is -0.18. Overlapping area represents the amount of risk that can be diversified away by holding AngioSoma and Protagenic Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Protagenic Therapeutics and AngioSoma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AngioSoma are associated (or correlated) with Protagenic Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Protagenic Therapeutics has no effect on the direction of AngioSoma i.e., AngioSoma and Protagenic Therapeutics go up and down completely randomly.

Pair Corralation between AngioSoma and Protagenic Therapeutics

Given the investment horizon of 90 days AngioSoma is expected to generate 1.61 times more return on investment than Protagenic Therapeutics. However, AngioSoma is 1.61 times more volatile than Protagenic Therapeutics. It trades about 0.06 of its potential returns per unit of risk. Protagenic Therapeutics is currently generating about -0.1 per unit of risk. If you would invest  0.09  in AngioSoma on February 5, 2024 and sell it today you would earn a total of  0.00  from holding AngioSoma or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

AngioSoma  vs.  Protagenic Therapeutics

AngioSoma

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in AngioSoma are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain basic indicators, AngioSoma exhibited solid returns over the last few months and may actually be approaching a breakup point.

Protagenic Therapeutics

Risk-Adjusted Performance

9 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Protagenic Therapeutics are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak forward indicators, Protagenic Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with AngioSoma and Protagenic Therapeutics

The main advantage of trading using opposite AngioSoma and Protagenic Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AngioSoma position performs unexpectedly, Protagenic Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Protagenic Therapeutics will offset losses from the drop in Protagenic Therapeutics' long position.

The idea behind AngioSoma and Protagenic Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.